|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2803 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K2039/545 | (2013.01) |
| (11) | Patento numeris | 3697817 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18800381.8 |
| Europos patento paraiškos padavimo data | 2018-10-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-08-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-10-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/056441 |
| Data | 2018-10-18 |
| (87) | Numeris | WO 2019/079548 |
| Data | 2019-04-25 |
| (30) | Numeris | Data | Šalis |
| 201762573835 P | 2017-10-18 | US |
| (72) |
TAKIMOTO, Chris Hidemi, Mizufune , US
CHAO, Mark, Ping , US
VOLKMER, Jens-Peter , US
|
| (73) |
Forty Seven, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | ANTI-CD47 AGENT-BASED OVARIAN CANCER THERAPY |
| ANTI-CD47 AGENT-BASED OVARIAN CANCER THERAPY |